{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:05:32Z","timestamp":1792101932184,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clbc.2024.03.014","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T16:37:43Z","timestamp":1712248663000},"page":"e503-e508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Screening Mammography for Males With Elevated Breast Cancer Risk, Mutation Carriers, and Gynecomastia"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8930-6932","authenticated-orcid":false,"given":"Ahuva","family":"Grubstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marva","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Jomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Friehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomit","family":"Tamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzippy","family":"Shochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Atar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanir M.","family":"Allweis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.clbc.2024.03.014_bib0001","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1056\/NEJMra1707939","article-title":"Breast cancer in men","volume":"378","author":"Giordano","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2024.03.014_bib0002","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jamaoncol.2019.2803","article-title":"Overall mortality after diagnosis of breast cancer in men vs women","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2024.03.014_bib0003","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ijc.32106","article-title":"Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy","volume":"145","author":"Rizzolo","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2024.03.014_bib0004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"CHEK2-breast cancer consortium, low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Heijboer","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.clbc.2024.03.014_bib0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.19.01907","article-title":"Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families","volume":"38","author":"Yang","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.03.014_bib0006","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jmg.2009.075176","article-title":"Risk of breast cancer in male BRCA2 carriers","volume":"47","author":"Evans","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.clbc.2024.03.014_bib0007","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/andr.13051","article-title":"Imaging in gynecomastia","volume":"9","author":"Billa","year":"2021","journal-title":"Andrology"},{"key":"10.1016\/j.clbc.2024.03.014_bib0008","doi-asserted-by":"crossref","first-page":"djt465","DOI":"10.1093\/jnci\/djt465","article-title":"Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results","volume":"106","author":"Brinton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2024.03.014_bib0009","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2407-2-26","article-title":"Male gynecomastia and risk for malignant tumours\u2014a cohort study","volume":"2","author":"Olsson","year":"2002","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2024.03.014_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10549-009-0379-0","article-title":"Etiologic factors for male breast cancer in the U.S. veterans affairs medical care system database","volume":"119","author":"Brinton","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2024.03.014_bib0011","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1148\/radiol.2019190971","article-title":"Breast cancer screening in high-risk men: a 12-year longitudinal observational study of male breast imaging utilization and outcomes","volume":"293","author":"Gao","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2024.03.014_bib0012","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10549-019-05338-1","article-title":"Mammographic screening in male patients at high risk for breast cancer: is it worth it?","volume":"177","author":"Marino","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2024.03.014_bib0013","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.clbc.2024.03.014_bib0014","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"ESMO guidelines committee, risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO clinical practice guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2024.03.014_bib0015","unstructured":"Bevers T.B., Niell B.L., Tyne C., et al. National Comprehensive Cancer Network. Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Journal of the National Comprehensive Cancer Network. vVersion 2.2024. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bone.pdf Accessed: March 3, 2024."},{"key":"10.1016\/j.clbc.2024.03.014_bib0016","unstructured":"Moonticciolo D.L., Hines S.L., Caplan K.L.S., et al. The ACR aappropriateness criteria\u00ae (AC). Journal of the American College of Radiology; 2023. https:\/\/www.acr.org\/Clinical-Resources\/ACR-Appropriateness-Criteria Accessed: July 10, 2023."},{"key":"10.1016\/j.clbc.2024.03.014_bib0017","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jbi\/wbac095","article-title":"Breast cancer screening in men","volume":"5","author":"Gao","year":"2023","journal-title":"J Breast Imaging"},{"key":"10.1016\/j.clbc.2024.03.014_bib0018","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1148\/radiology.191.3.8037795","article-title":"Mammography in men","volume":"191","author":"Cooper","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2024.03.014_bib0019","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9343(84)90353-X","article-title":"Gynecomastia in a hospitalized male population","volume":"77","author":"Niewoehner","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.clbc.2024.03.014_bib0020","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJMcp070677","article-title":"Clinical practice. Gynecomastia","volume":"357","author":"Braunstein","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2024.03.014_bib0021","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/tbj.12393","article-title":"Overuse of imaging the male breast-findings in 557 patients","volume":"21","author":"Lapid","year":"2015","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2024.03.014_bib0022","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/annonc\/mdx651","article-title":"Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG international male breast cancer program","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924001009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924001009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T10:03:29Z","timestamp":1722074609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820924001009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1526820924001009"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.03.014","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening Mammography for Males With Elevated Breast Cancer Risk, Mutation Carriers, and Gynecomastia","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}